Consumer drug imports would weaken safety system, U.S. says

Washington — Proposed legislation to allow importation of pharmaceuticals by individual U.S. consumers would weaken the proven regulatory system that ensures safety of the U.S. drug supply, a Food and Drug Administration (FDA) official says.

Read the full story at usinfo.state.gov